NCT00832169 Investigation of Rate+Extent of Excretion of Radioactivity in Urine+Faeces After Oral Administration of [14C]AZD1386 Status COMPLETED Phase PHASE1
NCT00831909 Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN Status COMPLETED Phase N/A
NCT00831779 Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00829127 AZD8075 Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers Status WITHDRAWN Phase PHASE1
NCT00829088 Investigation of Rate + Extent of Excretion of Radioactivity in Urine +Faeces After Oral Administration of [14C]AZD2066 Status COMPLETED Phase PHASE1
NCT00826969 Ciclesonide for the Treatment of Airway Hyperresponsiveness Status COMPLETED Phase PHASE4
NCT00826358 Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg Status COMPLETED Phase PHASE1
NCT00824746 Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00824057 Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2) Status COMPLETED Phase PHASE1
NCT00822887 Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas Status COMPLETED Phase PHASE1
NCT00821080 Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT00820417 Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib Status COMPLETED Phase PHASE1
NCT00819273 Investigation Into the Correlation of Plasma Hs-CRP Concentrations and Cardiovascular Risk in Korean Population Status COMPLETED Phase N/A
NCT00819234 Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin Status COMPLETED Phase PHASE2
NCT00819221 AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid Tumours Status TERMINATED Phase PHASE1
NCT00819104 A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components Status COMPLETED Phase PHASE4
NCT00818129 Study to Investigate Safety, Tolerability and PK Following Single and Multiple Ascending Doses of AZD7295 in Japanese Status COMPLETED Phase PHASE1